Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals

dc.authoridBayindir, Yasar/0000-0003-3930-774X
dc.authoridARITURK, Seda/0000-0002-8559-4148
dc.authorwosidBayindir, Yasar/T-1523-2017
dc.authorwosidARITURK, Seda/KOD-4936-2024
dc.contributor.authorSönmez, E
dc.contributor.authorSönmez, AS
dc.contributor.authorBayindir, Y
dc.contributor.authorCoskun, D
dc.contributor.authorAritürk, S
dc.date.accessioned2024-08-04T20:13:11Z
dc.date.available2024-08-04T20:13:11Z
dc.date.issued2002
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIn this prospective study, our aim was to test the effect of simultaneous administration of preS2 and S containing recombinant hepatitis B vaccine (S2SRHB) with tetanus toxoid (TT) to the individuals who did not respond after three doses of hepatitis B vaccine previously. There were three groups (healthy individuals, pregnant women, hemodialysis patients), each was divided into two subgroups as groups A and B. Group A received S2SRHB + TT and group B received only S2SRHB. We found that in groups receiving both vaccines, both seroconversion rate and antibody titer level were significantly higher (P < 0.05). In conclusion, simultaneous administration of S2SRHB + TT is more effective than administration of S2SRHB alone. (C) 2002 Elsevier Science Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/S0264-410X(02)00452-8
dc.identifier.endpage246en_US
dc.identifier.issn0264-410X
dc.identifier.issn1873-2518
dc.identifier.issue3-4en_US
dc.identifier.pmid12450699en_US
dc.identifier.scopus2-s2.0-0037073575en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage243en_US
dc.identifier.urihttps://doi.org/10.1016/S0264-410X(02)00452-8
dc.identifier.urihttps://hdl.handle.net/11616/93462
dc.identifier.volume21en_US
dc.identifier.wosWOS:000179723900012en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofVaccineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecthepatitis B vaccineen_US
dc.subjecttetanus toxoiden_US
dc.subjectnonresponderen_US
dc.titleAntihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individualsen_US
dc.typeArticleen_US

Dosyalar